النقرات: 474
المعرّف: 277018
2022
مقاييس جودة وأداء المقال
الجودة الإجمالية
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
تقييم الجودة بالذكاء الاصطناعي
لم يتم التحليل
Readership in this journal
Steady

Ranked #1 of 4 articles by views in Trends in cancer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
الملخص
Combination chemotherapy can cure certain leukemias and lymphomas, but most solid cancers are only curable at early stages. We review quantitative principles that explain the benefits of combining independently active cancer therapies in both settings. Understanding the mechanistic principles underlying curative treatments, including those developed many decades ago, is valuable for improving future combination therapies. We discuss contemporary evidence for long-established but currently neglected ideas of how combination therapy overcomes tumor heterogeneity. We show that a unified model of interpatient and intratumor heterogeneity describes historical progress in the treatment of pediatric acute lymphocytic leukemia (ALL), in which increasingly intensive combination regimens ultimately achieved high cure rates. We also describe three distinct aspects of drug independence that apply at different biological scales. The ability of these principles to quantitatively explain curative regimens suggests that supra-additive (synergistic) drug interactions are not required for successful combination therapy.
المفتاح المرجعي
pomeroy2022drugtrends استخدم هذا المفتاح للاستشهاد التلقائي في المخطوطة أثناء استخدام مدير المخطوطات أو مدير الأطروحات من SciMatic
المؤلفون
مجلة Trends in cancer
السنة 2022
DOI
10.1016/j.trecan.2022.06.009
URL
الكلمات المفتاحية

الاستشهادات

لم يتم العثور على استشهادات. لإضافة استشهاد، تواصل مع المشرف على info@scimatic.org

لا توجد تعليقات بعد. كن أول من يعلق على هذا المقال.